Concerns raised over LNG-IUS use in tamoxifen-treated women

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1279, 2001-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

LNG-IUS protects against tamoxifen-induced endometrial changes

By  

Inpharma, Vol. 1, Iss. 1265, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Tamoxifen-treated women at risk for oesophageal or gastric cancer?

By  

Reactions Weekly, Vol. 1, Iss. 1117, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Concerns raised over potential Phase 0 trial impacts

By  

Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Concerns over use of erlotinib in setting of hepatic impairment

By  

Reactions Weekly, Vol. 1, Iss. 1234, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Concerns voiced over study assessing CAM use in fibromyalgia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 484, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite